{
"procedureNumber": "EMEA/H/C/004214/0000",
"productName": "Xeljanz",
"productNumber": "1002",
"procedureType": "INITIAL_MA",
"activeSubstance": "tofacitinib citrate",
"additionalMonitoring": false,
"article58": false,
"atc": "L04AA29",
"biosimilar": true,
"conditionalApproval": true,
"exceptionalCircumstances": true,
"generic": false,
"legalAction": true,
"mah": "Pfizer",
"orphan": true,
"paediatric": true,
"productStatus": "INVALID",
"smallMediumEnterprise": true,
"plannedChmpOpinionDate": "2016-08-08T00:00:00",
"procedureStartDate": "2016-08-01T00:00:00"}
